Analysis
PublicMAPP BIOPHARMACEUTICAL, INC. holds $72.2M across 13 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the May 1, 2031 PoP end — agencies typically plan 12–18 months ahead.
Contract facts
NONENo full NAICS 541714 intel page yet. Browse NAICS intelligence
THIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (MAPP OR CONTRACTOR) IS FOR THE DEVELOPMENT OF MAPP?S THERAPEUTIC INTERVENTION MBP091, AS AN IMMUNOTHERAPY FOR THE TREATMENT OF MARBURG VIRUS INFECTION.
Recompete timing
PublicCurrent PoP ends May 1, 2031 (1722 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Nov 1, 2029.
Track recompete timing in SCOUT →Incumbent footprint
Public recordMAPP BIOPHARMACEUTICAL, INC. — $72.2M obligated across 13 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Live Demand-Fit + Displacement scoring, alerts on verdict flips, and watchlists. 90 days · $90 · no annual contract · cancel anytime
See all live recompete landscapes — who else is expiring, and where the openings are.
Open MAPP BIOPHARMACEUTICAL, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Frequently asked questions
What is contract 75A50122C00076?
75A50122C00076 (THIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (MAPP OR CONTRACTOR) IS FOR THE DEVELOPMENT OF MAPP…) is a Department of Health and Human Services (HHS) award with an estimated value of $110.9M, currently held by MAPP BIOPHARMACEUTICAL, INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.
Who is the incumbent on 75A50122C00076?
MAPP BIOPHARMACEUTICAL, INC. is the incumbent with $72.2M across 13 related awards in SCOUT’s public footprint. The current period of performance ends May 1, 2031.
When does 75A50122C00076 come up for recompete?
SCOUT tracks a period-of-performance end of May 1, 2031. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →